Search Results - "HILL, A. T"

Refine Results
  1. 1

    Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis by Murray, M. P, Turnbull, K, MacQuarrie, S, Pentland, J. L, Hill, A. T

    Published in The European respiratory journal (01-07-2009)
    “…Health-related quality of life is a potentially important marker for evaluating existing and new therapies in bronchiectasis. The Leicester Cough Questionnaire…”
    Get full text
    Journal Article
  2. 2

    A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis by Murray, M. P, Pentland, J. L, Hill, A. T

    Published in The European respiratory journal (01-11-2009)
    “…Regular chest physiotherapy is advocated in non-cystic fibrosis bronchiectasis despite little evidence supporting its routine use. This study aimed to…”
    Get full text
    Journal Article
  3. 3

    Assessing response to treatment of exacerbations of bronchiectasis in adults by Murray, M. P, Turnbull, K, MacQuarrie, S, Hill, A. T

    Published in The European respiratory journal (01-02-2009)
    “…The present study aimed to assess the effect of intravenous antibiotic therapy on clinical and laboratory end-points in exacerbations of noncystic fibrosis…”
    Get full text
    Journal Article
  4. 4

    Recurrent multistate outbreak of Salmonella Newport associated with tomatoes from contaminated fields, 2005 by GREENE, S. K., DALY, E. R., TALBOT, E. A., DEMMA, L. J., HOLZBAUER, S., PATEL, N. J., HILL, TA., WALDERHAUG, M. O., HOEKSTRA, R. M., LYNCH, M. F., PAINTER, J. A.

    Published in Epidemiology and infection (01-02-2008)
    “…Salmonella Newport causes more than an estimated 100 000 infections annually in the United States. In 2002, tomatoes grown and packed on the eastern shore of…”
    Get full text
    Journal Article
  5. 5

    Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis by Murray, M. P, Pentland, J. L, Turnbull, K, MacQuarrie, S, Hill, A. T

    Published in The European respiratory journal (01-08-2009)
    “…This study explored the utility of sputum colour in clinically stable patients with bronchiectasis. Interpretation of sputum colour between the doctor and the…”
    Get full text
    Journal Article
  6. 6

    Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia by Chalmers, J D, Singanayagam, A, Hill, A T

    Published in Thorax (01-08-2008)
    “…Admission blood pressure (BP) assessment is a central component of severity assessment for community acquired pneumonia. The aim of this study was to establish…”
    Get more information
    Journal Article
  7. 7

    A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis by Mandal, P, Sidhu, M.K, Kope, L, Pollock, W, Stevenson, L.M, Pentland, J.L, Turnbull, K, Mac Quarrie, S, Hill, A.T

    Published in Respiratory medicine (01-12-2012)
    “…Summary Aim The aim of our study was to assess the efficacy of pulmonary rehabilitation in addition to regular chest physiotherapy in non cystic fibrosis…”
    Get full text
    Journal Article
  8. 8

    Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia by SINGANAYAGAM, A, CHALMERS, J. D, AKRAM, A. R, HILL, A. T

    Published in The European respiratory journal (01-07-2011)
    “…The aim of this study was to investigate whether inhaled corticosteroid (ICS) use affects outcome in patients with chronic obstructive pulmonary disease (COPD)…”
    Get full text
    Journal Article
  9. 9

    Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis by CHALMERS, J. D, AKRAM, A. R, HILL, A. T

    Published in The European respiratory journal (01-04-2011)
    “…In order to identify, synthesise and interpret the evidence relating to strategies to increase the proportion of low-risk patients with community-acquired…”
    Get full text
    Journal Article
  10. 10

    Vascular complications are associated with poor outcome in community-acquired pneumonia by MANDAL, P, CHALMERS, J. D, CHOUDHURY, G, AKRAM, A. R, HILL, A. T

    Published in QJM : An International Journal of Medicine (01-06-2011)
    “…Recognition of cardiovascular risk factors is important for primary and secondary prevention strategies. Recent evidence has linked lower respiratory tract…”
    Get full text
    Journal Article
  11. 11

    British Thoracic Society guideline for non-CF bronchiectasis by Pasteur, M C, Bilton, D, Hill, A T

    Published in Thorax (01-07-2010)
    “…The diagnosis, investigation and particularly management of bronchiectasis has been largely empirical and the subject of relatively few controlled clinical…”
    Get more information
    Journal Article
  12. 12

    Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis by Choudhury, G., Mandal, P., Singanayagam, A., Akram, A.R., Chalmers, J.D., Hill, A.T.

    Published in Clinical microbiology and infection (01-12-2011)
    “…There are no studies to guide the optimal duration of therapy in severe community-acquired pneumonia (CAP). The aim of this study was to determine whether 7…”
    Get full text
    Journal Article
  13. 13

    Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients by CHOUDHURY, G, CHALMERS, J. D, MANDAL, P, AKRAM, A. R, MURRAY, M. P, SHORT, P, SINGANAYAGAM, A, HILL, A. T

    Published in The European respiratory journal (01-09-2011)
    “…This study investigates the reasons for hospitalisation in patients with low-risk (CURB-65 score 0-1) community-acquired pneumonia (CAP), with a view to…”
    Get full text
    Journal Article
  14. 14

    Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia by Akram, A.R., Chalmers, J.D., Hill, A.T.

    Published in QJM : An International Journal of Medicine (01-10-2011)
    “…Introduction: In community-acquired pneumonia, severity assessment tools, such as CRB65, CURB65 and Pneumonia Severity Index (PSI), have been promoted to…”
    Get full text
    Journal Article
  15. 15

    Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches by Brayden, D.J., Hill, T.A., Fairlie, D.P., Maher, S., Mrsny, R.J.

    Published in Advanced drug delivery reviews (2020)
    “…In its 33 years, ADDR has published regularly on the po5tential of oral delivery of biologics especially peptides and proteins. In the intervening period,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Comparison between conventional interrupted high-resolution CT and volume multidetector CT acquisition in the assessment of bronchiectasis by HILL, L. E, RITCHIE, G, WIGHTMAN, A. J, HILL, A. T, MURCHISON, J. T

    Published in British journal of radiology (2010)
    “…The aim of this study was to determine whether there is superior diagnostic accuracy for the detection and exclusion of bronchiectasis using 16-slice CT of the…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association by Singanayagam, A., Chalmers, J.D., Hill, A.T.

    Published in QJM : An International Journal of Medicine (01-06-2010)
    “…Inhaled corticosteroids (ICS) are commonly used in the treatment of chronic obstructive pulmonary disease. Recent large prospective trials have reported an…”
    Get full text
    Journal Article
  20. 20

    Alfaxalone induction dose following administration of medetomidine and butorphanol in the dog by Maddern, Kieren, Adams, Vicki J, Hill, Nichole A T, Leece, Elizabeth A

    Published in Veterinary anaesthesia and analgesia (01-01-2010)
    “…To determine in dogs the effects of medetomidine and butorphanol, alone and in combination, on the induction dose of alfaxalone and to describe the induction…”
    Get more information
    Journal Article